Cognitive assessment in a predominantly Hispanic and Native American population in New Mexico and its association with kidney transplant wait-listing.
Cognitive Dysfunction
/ diagnosis
Diabetes Mellitus
/ physiopathology
Female
Follow-Up Studies
Hispanic or Latino
/ psychology
Humans
Hypertension
/ physiopathology
Indians, North American
/ psychology
Kidney Failure, Chronic
/ mortality
Kidney Transplantation
/ mortality
Male
Middle Aged
New Mexico
/ epidemiology
Prevalence
Prognosis
Retrospective Studies
Survival Rate
Waiting Lists
/ mortality
Hispanic
Montreal Cognitive Assessment
Native American
cognitive impairment
kidney transplant wait-listing
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
07
10
2018
revised:
30
06
2019
accepted:
15
07
2019
pubmed:
25
7
2019
medline:
12
9
2020
entrez:
24
7
2019
Statut:
ppublish
Résumé
The association between cognitive function and the likelihood of kidney transplant (KT) wait-listing, especially in minority populations, has not been clearly delineated. We performed a retrospective review of our pre-KT patients, who consist mainly of Hispanics and Native Americans, over a 16-month period. We collected data on baseline demographics and the Montreal Cognitive Assessment (MoCA) score, at the initial KT evaluation. We defined cognitive impairment as MoCA scores of <24. We constructed linear regression models to identify associations between baseline characteristics with MoCA scores and used Cox proportional hazards models to assess associations between MoCA score and KT wait-listing. During the study period, 154 patients completed the MoCA during their initial evaluation. Mean (standard deviation) MoCA scores were 23.9 (4.6), with 58 (38%) participants scoring <24. Advanced age, lower education and being on dialysis were associated with lower MoCA scores. For every one-point increase in MoCA, the likelihood of being wait-listed increased 1.10-fold (95% CI 1.01-1.19, P = .022). Being Native American and having kidney disease due to diabetes or hypertension were associated with longer time to wait-listing. Cognitive impairment was common in our pre-KT patients and was associated with a lower likelihood of KT wait-listing.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13674Informations de copyright
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
O'Lone E, Connors M, Masson P, et al. Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2016;67(6):925-935.
Sarnak MJ, Tighiouart H, Scott TM, et al. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology. 2013;80(5):471-480.
Murray AM, Tupper DE, Knopman DS, et al. Cognitive impairment in hemodialysis patients is common. Neurology. 2006;67(2):216-223.
Singh Pooja P, Ng Y-H, Kidney UM. Transplantation among the elderly: challenges and opportunities to improve outcomes. Adv Chronic Kidney Dis. 2016;23(1):44-50.
Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis. 1997;30(1):41-49.
Kurella Tamura M, Yaffe K. Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int. 2011;79(1):14-22.
Drew DA, Weiner DE, Tighiouart H, et al. Cognitive function and all-cause mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2015;65(2):303-311.
Agganis BT, Weiner DE, Giang LM, et al. Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis. 2010;56(4):704-712.
Hain DJ. Cognitive function and adherence of older adults undergoing hemodialysis. Nephrol Nurs J. 2008;35(1):23-29.
Fujimaki H, Kasuya Y, Kagami S, et al. Acceptance of dialysis therapy in elderly patients with chronic renal failure. Nihon Ronen Igakkai Zasshi. 2003;40(1):41-46.
Patzer RE, Serper M, Reese PP, et al. Medication understanding, non-adherence, and clinical outcomes among adult kidney transplant recipients. Clin Transplant. 2016;30(10):1294-1305.
Thomas A, Ruck J, Shaffer A, et al. Impairment and graft loss in kidney transplant recipients. Am J Transpl. 2018;17(suppl 3):[abstract].
Schold JD, Gregg JA, Harman JS, Hall AG, Patton PR, Meier-Kriesche HU. Barriers to evaluation and wait listing for kidney transplantation. Clin J Am Soc Nephrol. 2011;6(7):1760-1767.
Freeman M, Pleis J, Bornemann K, et al. Has the department of veterans affairs found a way to avoid racial disparities in the evaluation process for kidney transplantation? Transplantation. 2017;101(6):1191-1199.
Myaskovsky L, Doebler D, Posluszny D, et al. Perceived discrimination predicts longer time to be accepted for kidney transplant. Transplantation. 2012;93(4):423-429.
Epstein A, Ayanian J, Keogh J, et al. Racial disparities in access to renal transplantation. N Engl J Med. 2000;343(21):1537-1544.
Johansen K, Zhang R, Huang Y, Patzer R, Kutner N. Association of race and insurance type with delayed assessment for kidney transplantation among patients initiating dialysis in the United States. Clin J Am Soc Nephrol. 2012;7(9):1490-1497.
Sequist TD, Narva AS, Stiles SK, Karp SK, Cass A, Ayanian JZ. Access to renal transplantation among American Indians and Hispanics. Am J Kidney Dis. 2004;44(2):344-352.
Joshi S, Gaynor JJ, Ciancio G. Review of ethnic disparities in access to renal transplantation. Clin Transplant. 2012;26(4):E337-343.
Gupta A, Montgomery RN, Bedros V, et al. Subclinical cognitive impairment and listing for kidney transplantation. Clin J Am Soc Nephrol. 2019;14:567-575.
Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
Tiffin-Richards FE, Costa AS, Holschbach B, et al. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS ONE. 2014;9(10):e106700.
Freitas SS. Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord. 2013;27(1):37-43.
Kaya YY. Validation of Montreal Cognitive Assessment and discriminant power of Montreal Cognitive Assessment subtests in patients with mild cognitive impairment and Alzheimer dementia in Turkish population. J Geriatr Psychiatry Neurol. 2014;27(2):103-109.
Lee Jun-Young JY. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol. 2008;21(2):104-110.
Luis Cheryl AC. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. Int J Geriatr Psychiatry. 2009;24(2):197-201.
McLennan SNS. Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. J Geriatr Psychiatry Neurol. 2011;24(1):33-38.
Tsai Chia-Fen CF. Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis. Int Psychoger. 2012;24(4):651-658.
Carson Nicole N. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry. 2018;33(2):379-388.
Rossetti HC, Lacritz LH, Cullum CM, Weiner MF. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology. 2011;77(13):1272-1275.
Angermann S, Baumann M, Steubl D, et al. Cognitive impairment in hemodialysis patients: implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening. PLoS ONE. 2017;12(10):e0184589.
Ojeda N, del Pino R, Ibarretxe-Bilbao N, Schretlen DJ, Peña J. Test de evaluación cognitiva de Montreal: normalización y estandarización de la prueba en población española. RevNeurol. 2016;63(11):0488-0496.
Delgado C, Araneda A, Behrens MI. Validation of the Spanish-language version of the Montreal Cognitive Assessment test in adults older than 60 years. Neurología. 2019;34(6):376-385.
Drew DA, Weiner DE, Tighiouart H, et al. Cognitive decline and its risk factors in prevalent hemodialysis patients. Am J Kidney Dis. 2017;69(6):780-787.
Foster RR. Cognitive impairment in advanced chronic kidney disease: the Canadian frailty observation and interventions trial. Am J Nephrol. 2016;44(6):473-480.
Kazley AS, Simpson KN, Chavin KD, Baliga P. Barriers facing patients referred for kidney transplant cause loss to follow-up. Kidney Int. 2012;82(9):1018-1023.
Axelrod DA, Guidinger MK, Finlayson S, et al. Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA. 2008;299(2):202-207.
Purnell TS, Hall YN, Boulware LE. Understanding and overcoming barriers to living kidney donation among racial and ethnic minorities in the United States. Adv Chronic Kidney Dis. 2012;19(4):244-251.
Joshi S, Gaynor JJ, Bayers S, et al. Disparities among Blacks, Hispanics, and Whites in time from starting dialysis to kidney transplant waitlisting. Transplantation. 2013;95(2):309-318.
Churak JM. Racial and ethnic disparities in renal transplantation. J Natl Med Assoc. 2005;97(2):153-160.
Williams AW. Health policy, disparities, and the kidney. Adv Chronic Kidney Dis. 2015;22(1):54-59.
Harhay MN, Reese PP. Frailty and cognitive deficits limit access to kidney transplantation. Clin J Am Soc Nephrol. 2019;14:493-495.
Haugen CE, Chu NM, Ying H, et al. Frailty and access to kidney transplantation. Clin J Am Soc Nephrol. 2019;14:576-582.
Delazer MM. Health numeracy and cognitive decline in advanced age. Aging Neuropsychol Cogn. 2013;20(6):639-659.
Pertl Marie-Theres MT. Do patients with mild cognitive impairment understand numerical health information? J Alzheimer's Dis: JAD. 2014;40(3):531-540.
Warsame F, Haugen CE, Ying H, et al. Limited health literacy and adverse outcomes among kidney transplant candidates. Am J Transpl. 2019;19(2):457-465.
Kurella Tamura M, Larive B, Unruh ML, et al. Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials. Clin J Am Soc Nephrol. 2010;5(8):1429-1438.
Pereira AA, Weiner DE, Scott T, et al. Subcortical cognitive impairment in dialysis patients. Hemodial Int. 2007;11(3):309-314.
Sullivan C, Leon J, Sayre S, et al. Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial. Clin J Am Soc Nephrol. 2012;7(10):1639-1645.
Bullock A, Burrows N, Narva AS. Vital signs: decrease in incidence of diabetes-related end-stage renal disease among American Indians/Alaska Natives - United States, 1996-2013. MMWR Morb Mortal Wkly Rep. 2017;66:26-32.
Lowe LP, Tranel D, Wallace RB, Welty TK. Type II diabetes and cognitive function: a population-based study of Native Americans. Diabetes Care. 1994;17:891-896.
Seliger SL, Sarnak MJ. Subclinical vascular disease of the brain in dialysis patients. Am J Kidney Dis. 2007;50(1):8-10.
Weiner DE, Scott TM, Giang LM, et al. Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis. 2011;58(5):773-781.
Drew DA, Bhadelia R, Tighiouart H, et al. Anatomic brain disease in hemodialysis patients: a cross-sectional study. Am J Kidney Dis. 2013;61(2):271-278.
Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol. 2013;24(3):353-363.
Tripepi G, Mattace-Raso F, Rapisarda F, et al. Traditional and nontraditional risk factors as predictors of cerebrovascular events in patients with end stage renal disease. J Hypertens. 2010;28(12):2468-2474.
Narva A, Stiles S, Karp S, Turak A. Access of Native Americans to renal transplantation in Arizona and New Mexico. Blood Purif. 1996;14(4):293-304.
Yeates KE, Cass A, Sequist TD, et al. Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int. 2009;76(6):659-664.
Vogel SJ, Banks SJ, Cummings JL, Miller JB. Concordance of the Montreal cognitive assessment with standard neuropsychological measures. Alzheimer's Dementia: Diag Assess Dis Monit. 2015;1(3):289-294.